Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhGH for IVF/ICSI in Poor Ovarian Reserve
NCT04588844Unknown
- Sponsor
- Shandong University
- Start
- Dec 2020
- Primary completion
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Randomised, open-label trial of genotropin miniquick in Diminished Ovarian Reserve (DOR) (2 arms), sponsored by Shandong University. Primary endpoints: Blastocyst formation rate at 1 year and Live birth rate at 1 year. Status: unknown.
02
Drugs
genotropin miniquick
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT04588844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04588844.